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Interferon, alternatively termed PML nuclear bodies (PML-NBs) or PML oncogenic domains
(PODs), have been discovered approximately 15 years ago as a nuclear substructure that is targeted by a
variety of viruses belonging to different viral families. This review will summarize the most important
structural and functional characteristics of ND10 and its major protein constituents followed by a discussion
of the current view regarding the role of this subnuclear structure for various DNA and RNA viruses with an
emphasis on herpesviruses. It is concluded that accumulating evidence argues for an involvement of ND10 in
host antiviral defenses either via mediating an intrinsic immune response against speciﬁc viruses or via
acting as a component of the cellular interferon pathway.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionViruses, even the most complex ones, rely on the cellular
machinery in order to replicate efﬁciently. Consequently, viruses
have evolved in tight association to the host cell in order to usurp the
cellular apparatus that is necessary for their replication as well as to
cope with the various antiviral defense mechanisms the cell has
developed during co-evolution. Over a decade ago, a cellular sub-
nuclear structure known as nuclear domain 10 (ND10) has been
identiﬁed as a frequent target site for a variety of different viruses
during the course of infection. Most of the work so far has mainly
focused on nuclear-replicating DNA viruses but there is accumulating
evidence that the replication of RNA viruses is also inﬂuenced by this
nuclear substructure. However, there has always been a controversial
debate about the functional role of ND10 for viral replication. The aim
of this article is to summarize the current state of knowledge
concerning the interplay of different viruses with ND10 during
infection in light of what is presently known about the functional
signiﬁcance of these interactions. There will be an emphasis on
herpesviruses, since these have been most extensively studied with
respect to the functional consequences of ND10 association.
2. Structure and composition of ND10
Nuclear domains 10 (ND10), also referred to as nuclear dots, PML
nuclear bodies (PML-NBs), or PML oncogenic domains (PODs), are+49 9131 8522101.
rlangen.de (T. Stamminger).
l rights reserved.dynamic, spherical, macromolecular structures which represent
accumulations of multiple cellular proteins that assemble in distinct
foci within the interchromosomal space of the nucleus [1]. Like many
transcription or RNA processing factors, ND10 bodies are associated
with the nuclear matrix, since treatment with RNase or DNase does
not alter their morphology [2,3]. The apparent size of PML-NBs ranges
from 0.2 to 1 μm, and their frequency depends on cell type and status,
varying from 2 or 3 to as many as 30 per cell [3]. There is an ever-
expanding list of proteins that have been reported to be present in or
associated with ND10 structures. These proteins can be subdivided
into two classes, based on whether they are constitutively present at
ND10 or only under certain circumstances. Permanently localized at
ND10 are the major components PML (promyelocytic leukemia
protein), hDaxx, Sp100 (speckled protein of 100 kDa), SUMO-1
(small ubiquitin-related modiﬁer 1), and the Bloom syndrome heli-
case BLM [1]. On the contrary, quite a variety of factors can be found at
ND10 only under certain conditions (e.g. components of the DNA
repair machinery) [4–6] or upon overexpression (e.g. BRCA1 — breast
cancer protein 1) [1,7]. However, in the latter case, it has to be
questioned, whether such polypeptides constitute natural ND10
components, as more and more data suggest a role of ND10 in the
degradation of mis- or unfolded protein aggregates [8,9]. Thus, as the
composition of ND10 varies both within and between cells, it is
tempting to speculate that ND10 represent functionally heteroge-
neous protein accumulations.
The Sp100 protein was the ﬁrst ND10 constituent identiﬁed using
sera of patients suffering from the autoimmune disease primary
biliary cirrhosis (PBC) [10]. Thereafter, PML was discovered as the
deﬁning factor of ND10. It functions as a kind of scaffold protein that is
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recruits other ND10-associated proteins like hDaxx to this subnuclear
structure [11,12]. Since PML constitutes the key component of ND10
integrity, loss of PML consequently leads to a dispersal of ND10-
resident proteins as observed in mouse PML-null ﬁbroblasts [11,12] or
human PML-knockdown (PML-kd) ﬁbroblasts [13,14].
3. The major ND10 constituents and their functions
3.1. PML
The PML protein was originally discovered in patients suffering
from acute promyelocytic leukemia (APL), where a reciprocal
chromosomal translocation resulting in a fusion of the PML protein
to the retinoic acid receptor α turned out to be responsible for this
hematopoietic malignancy [15]. PML, also known as TRIM19, belongs
to the RBCC or tri-partitemotif family (TRIM) of proteins that include a
RING ﬁnger, one or two B-boxes (cysteine/histidine-rich motifs) and a
predicted α-helical coiled-coil domain [16]. This motif, which allows
PML to interact with other proteins as well as to homo-oligomerize, is
essential for ND10 formation and for the function of PML as a growth-
and transformation-suppressor [17]. Due to differential splicing of the
PML gene transcript which consists of nine exons, at least seven
different PML isoforms (I to VII) are expressedwithin cells, all sharing a
common N-terminus but varying in their C-termini. The functions of
the PML splice variants are not known. Alternative splicing could add
new functional domains to the protein or may be an important
mechanism for generating diverse PML-binding interfaces for a variety
of factors. Moreover, all isoforms having molecular weights ranging
from 48 to 97 kDa (kilo Dalton), are subject to posttranslational
modiﬁcations like phosphorylation [18] or conjugation to the
ubiquitin-homologous protein SUMO (SUMOylation) [19,20]. In addi-
tion to three SUMOmodiﬁcation sites at lysine residues 65 (in the RING
ﬁnger domain),160 (in the B1 box), and 490 (in the nuclear localization
signal) [21], PML also contains a SUMO binding motif that enables it to
interact noncovalently with SUMO [22]. Covalent as well as non-
covalent SUMOmodiﬁcation is extremely important for the function of
PML to orchestrate ND10 formation as clearly illustrated in case of the
recruitment of hDaxx to this subnuclear structure [12,22,23].
3.2. hDaxx
HDaxx is a highly conserved nuclear protein that contains a serine/
proline/threonine-rich domain, an acidic domain, a coiled-coil region,
and two paired amphipathic helices [24–27]. It has been recognized as
a regulator of both apoptosis and gene expression [28]. In gene
regulation, hDaxx has been shown to function as a transcriptional
corepressor. It negatively affects gene expression by suppressing the
activity of several transcription factors, including Ets-1 (E twenty-six
1) [29], NF-κB (nuclear factor κB) [30], Pax3 [24], E2F-1 [31], Smad4
[32], p53 family members [33], and glucocorticoid, mineralocorticoid
and androgen receptors [34]. Recent ﬁndings indicate that hDaxx
associates via its newly identiﬁed SUMO-interacting motif (SIM) with
SUMOylated DNA-binding transcription factors [23], thereby recruit-
ing proteins involved in transcriptional repression, such as histone
deacetylase 1 (HDAC1) [26], HDAC2 [35], DNA methyltransferase 1
(DNMT1) [36], or ATRX (α-thalassaemia/mental retardation syn-
drome X-linked) [37,38], a member of the SNF2 family of chromatin
remodeling enzymes, to targeted promoters. The transrepressive
effect of hDaxx, in turn, is modulated by its subnuclear compartmen-
talization. The SIM enables hDaxx to also non-covalently interact with
SUMOylated PML, resulting in the sequestration of nucleoplasmic
hDaxx to ND10 [22,23], which is accompanied by attenuation of its
inhibitory function [26]. Beside ND10, hDaxx can also be targeted to
the nucleolus, centromeres, or heterochromatin through its interac-
tions with either the nucleolar protein MSP58 (microspherule proteinof 58 kDa) [39], the centromeric protein CENP-C [27], or the
heterochromatin-associated factor ATRX [37]. Taken together, these
observations imply that, depending on its subnuclear localization,
hDaxx seems to fulﬁll distinct functions.
3.3. Sp100
Like PML, the Sp100 protein represents a permanent ND10
constituent which is expressed via alternative splicing from a single
gene transcript giving rise to four different isoforms designated as
Sp100A [10], Sp100B [40], Sp100C [41], and Sp100-HMG [42,43]. All
Sp100 splice variants share a common N-terminus harboring an HSR
(homogeneously staining region) motif responsible for homo-oligo-
merization of Sp100 and its targeting to ND10 as well as a binding site
for the non-histone chromosomal DNA-binding protein HP1 (hetero-
chromatin protein 1). The larger splice variants Sp100B, -C, and -HMG
encode additional functional motifs at the C-terminus such as a SAND
domain (common to all three longer isoforms), a PHD ﬁnger-
bromodomain (Sp100-C), or an HMG box (Sp100-HMG). All three
motifs represent potential DNA-binding domains which can fre-
quently be found in proteins affecting chromatin structure [44].
Together with the observation that Sp100 interacts with hetero-
chromatin protein HP1 [42], which plays a central role in establishing
a stable heterochromatic network, this suggests a role of Sp100 in
transcriptional regulation. Indeed, the isoform Sp100B has been
shown to function as a transcriptional repressor of both cellular and
viral promoters in transient expression experiments [45]. In addition,
as recently reported, Sp100B preferentially associates via its SAND
domain with DNA sequences containing unmethylated CpG dinucleo-
tides, sincemethylation of cytosines in the CpG context abrogates DNA
binding of Sp100B [46]. This ﬁnding prompted the authors to
speculate that the preference of Sp100B for non-methylated CpGs
could provide a mechanism to speciﬁcally target this isoform to
foreign DNA (including viral genomes), which is predominantly
hypomethylated [46].
Like many ND10 constituents, including PML and hDaxx
[20,47,48], Sp100 is also subject to posttranslational modiﬁcation
by SUMO [48]. While SUMOylation of Sp100 is not required for its
ND10 localization [49], it has been shown to enhance the interaction
with HP1 and thus to stabilize Sp100-HP1 complexes suggesting that
the functional interplay of Sp100 between ND10 and heterochroma-
tin could be regulated in this way [41]. Recent data indicate, that the
SUMO modiﬁcation status as well as the relative expression level of
Sp100 are to some extent regulated, either directly or indirectly, by
PML [13]. SiRNA-mediated knockdown of PML resulted in an
apparent reduction in the abundance of Sp100-HMG and the
SUMO-modiﬁed form of Sp100A, with a concomitant increase in
unmodiﬁed Sp100A [13]. Thus, Sp100 metabolism seems to be closely
linked to that of PML.
4. Functions of ND10
Unlike other, more specialized subnuclear structures such as Cajal
and Polycomb group bodies, PML-NBs are functionally promiscuous
and have been implicated in the regulation of diverse cellular
processes. The research in a variety of ﬁelds has produced a substantial
literature that links ND10 to oncogenesis [50], DNA damage repair [5],
apoptosis [51,52], stress response [53], senescence [54], the ubiquitin
pathway [55] as well as to the regulation of gene expression [56].
Despite these various cellular responses, the functions of ND10 are still
not fully understood.
In the absence of a clear understanding of the biochemical function
of ND10, the following, not mutually exclusive, models have been
proposed to explain how this subnuclear structure could exert its
biological functions [1,56–59]: (i) PML-NBs might operate as nuclear
depots or storage sites for the accumulation of proteins both under
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well as under normal conditions to accumulate proteins that can be
released or relocated elsewhere as required in order to control their
availability at nucleoplasmic sites other than ND10; (ii) PML-NBs may
illustrate “catalytic surfaces” where the post-translational modiﬁca-
tion of proteins takes place (e.g. SUMOylation); (iii) ND10 domains
could be active sites for deﬁned nuclear functions such as transcrip-
tional and chromatin regulation.
With respect to the latter activity, evidence continues to
accumulate that ND10 play a role for transcriptional regulation since
numerous transcription factors and transcriptional regulators dyna-
mically localize to these domains [56] and nascent RNA has been
detected in the immediate vicinity of PML-NBs [60]. Nevertheless, the
exact molecular mechanisms of ND10-mediated transcriptional
regulation remain elusive. Several studies indicate that PML-NBs
might regulate transcription by modulating the nucleoplasmic
availability or the activity status of transcription factors [56,61].
While not contradicting this model, another emerging idea is that
ND10 could also control transcriptional activities indirectly on an
epigenetic level by participating in chromatin-remodeling processes.
For the ND10 components PML and hDaxx, an associationwith histone
deacetylases (HDACs) [26,35,62] or DNA methyltransferases [63,64],
which all exhibit a transcriptionally repressive function, has been
demonstrated. Certain PML isoforms, in addition, have been shown to
form complexes with multiple corepressors like c-Ski, N-CoR, mSin3A
[65], or the novel KRAB-zinc ﬁnger repressor PAROT (PML-associated
repressor of transcription) [66] as well as to silence transcription by
recruiting the histone methyltransferase SUV39H1 [67] or the
polycomb group (PcG) protein EZH2 [68], one of the core components
of the Polycomb repressive complexes (PRC) 2/3/4. Similarly, Sp100
also behaves as a transcriptional repressor by interacting with the
heterochromatin protein HP1 [42,45]. Thus, the fact that several ND10
components associate with potent repressors of gene expression gave
rise to the idea of ND10 acting as sites of transcriptional repression. In
contrast, however, the presence of transcriptional activators like the
acetyltransferase CBP or p53 at ND10 has likewise been described
[69,70], reﬂecting the still controversial debate about the role of this
subnuclear structure in regulating gene expression.
Finally, as will be discussed in this review, ND10 have been
implicated to play an important role during viral infection [4,59,71–
73]. For instance, there are several indications that ND10 are linked to
the interferon-mediated antiviral response of the cell [74,75]. Many
ND10 proteins, including the major components PML and Sp100, are
interferon (IFN) inducible [74,76,77]. Although PML and Sp100 are
expressed in the absence of IFN, their expression is greatly increased
and directly induced by type I (IFN-α and IFN-β) as well as type II (IFN-
γ) interferons through an “IFN-stimulated response element” (ISRE)
and an “IFN-gamma activation site” (GAS) which are located within
the promoters of their genes [78,79]. As a consequence of this, in
response to interferon treatment of cells, the number, size, and
intensity of PML-NBs increases [80]. The study of ND10 structures in
the context of viral infection provides further evidence to implicate
ND10 in the IFN pathway. As speciﬁed in detail in the sections below,
many viruses have evolved polypeptides in order to compromise
ND10 integrity to variable extents. Such kind of structural modiﬁca-
tions of ND10 have been shown to frequently correlate with the
efﬁciency of viral infection and thus could be viewed as part of a viral
strategy to evade an antiviral function of ND10 [75]. The following
chapters will sum up the current state of knowledge concerning the
potential role of ND10 for the replication of nuclear- and cytoplasmic-
replicating DNA as well as RNA viruses.
5. DNA viruses and ND10
Interest in the interaction between DNAviruses and ND10was ﬁrst
sparked by the observation that infection by herpes simplex virus type1 (HSV-1) caused a rapid destruction of this subnuclear structure [81].
Subsequently, it was found that the parental genomes and replication
complexes of HSV-1 and adenoviruses were preferentially located in
close association with ND10 [82,83]. This observation has been
extended to include the polyomavirus simian virus 40 (SV40) and
papillomaviruses as well as members of all sub-families of the
herpesviridae [71,73]. Thus, it appears to be a general feature of
nuclear-replicating DNA viruses that their parental genomes prefer-
entially become associated with ND10, and that their initial sites of
transcription and the development of DNA replication centers are
frequently juxtaposed to these domains or their remnants. The
intimate spatial association between viruses and ND10 has raised
important questions: What are the viral and host cell factors that are
responsible for the association and what are the functional con-
sequences of this tight interaction? Some progress has been made
within the last years towards partially answering these questions.
5.1. Herpes simplex virus type 1 (HSV-1)
HSV-1, a member of the neurotropic alpha sub-family of
herpesviruses, is able to attain a stable latent state in neurons after
a primary infection of epithelial cells. It was the ﬁrst virus to be shown
to affect ND10 morphology during infection. The initial observation
that HSV-1 disrupts ND10 but an ICP0-deﬁcient mutant does not [81],
rapidly led to the identiﬁcation of ICP0 being necessary and sufﬁcient
for this effect [84,85]. ICP0 is a RING ﬁnger protein that is very
important in certain cell types for initiating viral lytic infection and
contributes to the reactivation of quiescent viral genomes in cultured
cells as well as of latent virus fromneurons inmousemodels [86]. ICP0
initially precisely colocalizes with ND10 at early times upon infection
and subsequently mediates the dis-aggregation of PML-NBs by
inducing the degradation of the SUMO-1 modiﬁed forms of PML and
Sp100 [87–90], leading to the release and dispersal of other ND10
proteins. This effect of ICP0 on ND10 is dependent upon ICP0 having
an intact RING ﬁnger motif [84] and reﬂects its ability as an E3
ubiquitin ligase to target speciﬁc proteins for degradation by the
proteasome [91]. However, it is likely that the apparent loss of various
isoforms of Sp100 during wt HSV-1 infection is a consequence of ICP0-
induced degradation of PML, rather than being a direct effect of ICP0
on Sp100 itself [13]. Disruption of ND10 by ICP0 correlates with its role
in stimulating HSV-1 lytic infection and reactivation from quiescence
or latency [86].
Especially by using an ICP0-deletion virus being defective in the
ability to modify ND10, a preferential localization of parental HSV-1
DNA in close proximity to ND10 was demonstrated via in situ
hybridization [82]. This observation could also be conﬁrmed in wt
HSV-1-infected cells when early time points prior to ICP0-mediated
ND10 dispersal were analyzed [82]. Subsequent infection experiments
with ﬂuorescence-tagged viruses revealed that ND10 do not only
serve as a nucleation site for incoming HSV-1 genomes but also for
several viral regulatory proteins. Two virus particle-associated
tegument proteins, VP13/14 and VP22 have been shown to accumulate
in punctate nuclear dots which are distinct from but closely adjacent
to ICP0 foci, and thus ND10 [92]. Similarly, by using the same
technique, the IE transcriptional regulatory protein ICP4 was found to
form dot-like accumulations at early times of infection many of which
are juxtaposed to ND10 [93]. ICP4, which is essential for the activation
of viral early and late gene expression, functions by binding to viral
DNA and by interacting with components of the host transcriptional
apparatus [94]. Indeed, as determined by in situ hybridization, ICP4
foci represent ICP4 molecules being recruited onto ND10-localized
parental viral genomes as they directly colocalize with input HSV-1
DNA and later develop into replication compartments as infection
progresses [93,95,96]. Since ICP4 accumulations only form during
infection and are not detectable in transiently transfected cells, this
implies that a viral factor, presumably the viral DNA, contributes to
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ICP4 foci also contain the regulatory protein ICP27 [95], which plays a
crucial role in the regulation of productive infection by functioning in
the processing and efﬁcient export of viral mRNAs [94]. The detection
of ICP27 colocalizing with ICP4 led to the suggestion that these foci
represent viral nucleoprotein complexes that are biologically active
and engaged in viral transcription [95].
Infection studies using the ICP0 mutant virus provided additional
evidence that viral replication compartments start to initiate in the
periphery of PML-NBs [83] and recent experiments using time-lapse
microscopy to study the fate of incoming HSV-1 amplicon genomes
implied that ND10-associated DNA has an increased probability of
being replicated [97]. This ﬁnding indicated that not all viral genomes
in infected cells are functionally equivalent and that progression of
HSV-1 artiﬁcial infectious replicons into active replication centers was
favored by a close localization to ND10. In the same study, the
frequency of ND10 association could be enhanced if active HSV-1
transcription units (e.g. a transcription cassette containing ICP4
binding sites) were included in the amplicon, suggesting that the
formation of viral nucleoprotein complexes triggers ND10 localization.
In agreement with this, Tang et al. [98] demonstrated that the viral
origin of replication (oriS) together with the IE proteins ICP4 and
ICP27 are the minimum HSV-1 components necessary to localize
transcriptionally active DNA at ND10. However, these ﬁndings are in
apparent conﬂict with earlier evidence showing that preventing
protein or RNA synthesis at the time of infection did not inhibit the
positioning of incoming viral genomes at ND10 [82]. Similarly, recent
data based on an HSV-1 mutant with lesions that inactivate VP16,
ICP0, and ICP4, which enables the establishment of cell cultures
containing quiescent viral genomes revealed that transcriptionally
inactive viral DNA still associates with ND10 [99]. This further
strengthens the assumption that neither newly synthesized viral
proteins nor extensive viral transcription are required for viral
genome localization at ND10. Moreover, these observations illustrate
that the intimate connections between HSV-1 DNA and ND10 that
occur during lytic replication can also be extended to latent-like
infections. Interestingly, in the latter case, abnormally enlarged ND10
are detectable, which appear as ring-like accumulations when
analyzed by confocal microscopy but which actually represent
spherical structures, with PML enclosing the viral DNA in the interior
[99].
Nonetheless, also in the apparent absence of active transcription,
incoming viral genomes are certainly never completely naked as
transcription complexes containing the viral tegument protein VP16
as well as the host factors Oct-1 and HCF or other cellular chromatin or
DNA binding proteins accumulate on them further encouraging the
hypothesis that the formation of foreign nucleoprotein complexes or
chromatin assembly mechanisms in general may cause their ND10
localization. ND10 association as a consequence of recognition of
foreign nucleoprotein complexes has also been concluded by another
study, in which chromosomal integration of a series of gene cassettes
containing lacO and tetO binding sites resulted in an artiﬁcial
tethering of the host chromosome to ND10 upon expression of
EGFP–lacI or VP16–TetR fusion proteins [100]. Alternatively, since
accumulating evidence suggests that ND10-like structures generally
associate with sites of DNA damage, viral genome induced activation
of the cellular DNA repair machinery could also be considered as a
possible mechanism for ND10 sequestration [4].
The identiﬁcation of cellular factors that are responsible for the
localization of incoming viral genomes at ND10 likewise awaits
further investigation. Recent studies conducted in cells being
extensively depleted for PML demonstrated that Sp100 or hDaxx are
efﬁciently recruited to HSV-1 as well as HCMV nucleoprotein
complexes even in the absence of PML [13,14]. Therefore, it appears
that PML is not necessarily required for the subnuclear positioning of
other ND10 proteins in response to viral infection. Furthermore,simultaneous knockdown (kd) of PML and Sp100 does not prevent
accumulation of hDaxx at input HSV-1 DNA [101]. Similarly, infection
of PML and hDaxx double-kd cells with HCMV still induces the
targeting of Sp100 to viral nucleoprotein complexes (N. Tavalai and T.
Stamminger, unpublished observation). Taken together, these data
support the notion that all three major ND10 constituents individually
contain determinants that enable their localization to sites associated
with viral nucleoprotein complexes.
Although the exact viral and cellular factors involved in virus
genome association with ND10 still remain to be determined, several
lines of evidence indicate that the interaction between viral
nucleoprotein complexes and ND10 is due to a dynamic response of
the cell. One argument in favor of this hypothesis is the observation
that HSV-1 as well as HCMV infection of PML-kd cells, in which hDaxx
and Sp100 are normally diffusely distributed, elicits the reorganiza-
tion of ND10-like accumulations of both proteins [13,14]. Moreover,
Everett and colleagues carried out experiments in which they
examined cells at the edge of developing plaque. The consequential
unidirectional entry of virions into neighboring cells resulted in an
asymmetric distribution of not only the incoming HSV-1 genomes but
also the adjacently located ND10 structures [95,96]. Given the
apparently random distribution of PML-NBs in uninfected cells this
ﬁnding underlines the notion that ND10 components actively relocate
to sites of HSV-1 nucleoprotein complexes. Since at least a subgroup of
ND10 is quite immobile [102] and individual ND10 constituents
dynamically exchange between PML-NBs and the surrounding
nucleoplasm [69,96], it is more likely that novel ND10 foci form in
association with viral genomes rather than pre-existing domains
move to these sites.
Taking into account that ND10 are IFN-inducible and actively target
incoming DNA viruses, this makes it tempting to suggest an antiviral
role for this nuclear substructure. In accordance with this assumption
it has been shown that an ICP0-negative HSV-1, which fails to disrupt
ND10 and thus to counteract the cellular response, is hypersensitive to
the effects of IFN in certain cultured cell lines [103,104] and exhibits
low pathogenicity in normal mice in vivo, while infection of mice that
are unable to mount an interferon response restores its replication
capacity [105]. Although neither infection with wt nor ICP0-deﬁcient
HSV-1 is enhanced in the absence of PML in PML−/−murine embryonic
ﬁbroblasts (MEFs) compared to control PML+/+ MEFs, the replication of
the ICP0-deletion virus is substantially compromised by IFN treatment
of these cells in the presence but not absence of PML [106]. These
results suggest that PML contributes to the cellular IFN-mediated
restriction of HSV-1 infection and that one function of ICP0 is to
efﬁciently counteract the repressive effect of PML. However, neither
exogenous expression of PML isoforms III, IV, nor VI turned out to
affect virus yield, even though PML overexpression blocked the
dispersal of ND10 in response to HSV-1 infection [87,107,108]. In light
of the increasing evidence that different PML isoforms possess distinct
properties, one possible explanation could be that the PML variants
used in those studies may play a minor role in the host IFN-mediated
antiviral response. In addition, in contrast to the prior ﬁxed cell
analyses, live-cell imaging experiments clearly demonstrated that
large ND10 aggregates as a consequence of high-level expression of
PML are nonetheless subject to extensive modiﬁcation in terms of
both content and morphology during HSV-1 infection [107].
In principle, it was not until the recent generation of physiologi-
cally more relevant knockdown cells being derived from the natural
human host, in which individual ND10 components were depleted,
that substantial advances in understanding the biological relevance of
ND10 for HSV-1 replication were made. Although infection of cells
with an shRNA-mediated down-regulation of either PML or Sp100 had
no effect on wt HSV-1 replication, it resulted in a signiﬁcant increase
in the efﬁcacy of gene expression and plaque formation of an ICP0-null
mutant virus [13,101]. On the same theme, Negorev et al. [109]
previously reported that the restrictive activity of Sp100 is based on
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with this, overexpression of Sp100B but not Sp100A suppressed HSV-1
gene expression [45,109]. Moreover, by speciﬁcally depleting the
repressive Sp100 variants B, C, and HMG using RNA interference, these
proteins could be conﬁrmed as an essential part of the IFN-mediated
restriction of HSV-1 replication [109]. Interestingly, simultaneous
knockdown of both ND10 proteins, PML as well as Sp100, further
stimulated gene expression and plaque forming ability of the ICP0-
knockout virus but did not completely eliminate its replication defect
indicating the involvement of additional repressive factors [101].
Nevertheless, this ﬁnding adds more weight to the concept of ND10 as
an intrinsic antiviral defensemechanism of the cell as individual ND10
components contribute independently to the silencing of viral gene
expression. Furthermore, a very recent publication suggested that not
only nuclear PML but also a cytoplasmic PML isoform, lacking exons 5
and 6, could potentially contribute to an intrinsic cellular defense
against HSV-1 by cytoplasmic sequestration of ICP0 [110].
5.2. Human cytomegalovirus (HCMV)
Also in case of HCMV, the prototype of the β-subgroup of
herpesviruses, parental viral genomes associate with ND10 followed
by the targeting of newly synthesized viral IE transactivators IE1 and
IE2 to this subnuclear structure [111,112]. It was reported that both
regulatory proteins, which are essential for initiating the lytic
replication program of HCMV [94], become part of an immediate
transcript environment (ITE) consisting of IE transcripts and the
spliceosome assembly factor SC35, which evolves at ND10-associated
viral genomes [112]. Detailed analysis revealed that there are subtle
differences in the localization pattern of IE1 and IE2 at ND10 that may
reﬂect on their respective functions. While IE1 perfectly colocalizes
with all ND10 structures of the nucleus, and transfection experiments
demonstrated that this localization is inherent in the protein, only
transiently expressed IE2 illustrates a perfect colocalizationwith ND10
[111–113]. In the context of infection, the IE2 protein can also be found
adjacent to these domains where it accumulates juxtaposed to the
subpopulation of PML-NBs with viral transcripts attached [112–114].
While previous workwith ﬁxed cells suggested that some IE2 foci may
colocalize, others may be adjacent to ND10, recent time-lapse
experiments, instead, revealed an unexpectedly high dynamic of the
relative locations of IE2 and ND10 foci, changing within minutes
between precise colocalization and juxtaposition [115]. One important
implication of this ﬁnding is that IE2 and ND10 foci represent separate
structures which independently form in the context of viral infection.
In fact, the same study provided evidence that it is the viral DNA, but
not ND10, that acts as an important determinant for the formation of
dot-like IE2 accumulations during infection [115]. In this regard, it
should be noted that oligomerization of IE2 on HCMV-DNA early after
infection is strikingly reminiscent of its functional analogous protein
ICP4 of HSV-1 (see 5.1.), giving rise to the idea, that the formation of a
viral nucleoprotein complex between the respective major transcrip-
tional transactivator and viral DNA is likely to be a critical step
common to the alpha- and betaherpesviruses.
The pronounced interplay between IE2 and ND10 structures,
however, can only be observed within a narrow time window due to
the action of the IE1 protein, which is responsible for the disruption of
ND10 during infection with HCMV [111,113,116]. As a mechanism for
this, it has been proposed that IE1 abrogates the SUMOylation of PML
[117,118], but in contrast to ICP0 of HSV-1 (see 5.1.), IE1 does not
require proteasome activity for this effect [119] nor does it possess any
intrinsic desumoylation activity in vitro [120]. Thus, although the
biochemical basis for ND10 disruption by IE1 remains unclear,
structural modiﬁcation of ND10 has been shown to correlate with
the functional activities of IE1 in transcriptional regulation, resulting
in increased efﬁcacy of viral replication. In the same context, HCMV
infection, on the contrary, progresses poorly in cells expressing highlevels of exogenous PML due to a delay in IE1-mediated ND10
dispersal leading to impaired establishment of replication centers and
reduced production of early and late proteins [121]. Consequently,
these data already implied a repressive function of PML on HCMV
replication which is counteracted by the IE1-induced reorganization
of ND10. Conclusive evidence for this assumptionwas ﬁnally obtained
from infection studies using cells being devoid of genuine ND10:
extensive, siRNA-mediated depletion of PML in primary human
ﬁbroblasts signiﬁcantly increased the plaque-forming efﬁciency of
HCMV as a result of an augmented IE gene expression [14]. This effect
was considerably enhanced after infection of PML-kd cells with an
IE1-deﬁcient HCMV, since loss of PML complemented the growth
defect of this mutant virus [14]. Thus, the clear demonstration of an
intrinsic antiviral activity of the major ND10 component PML was an
important step forward in understanding the functional signiﬁcance
of the intimate relationship between HCMV and ND10.
The interaction of HCMV proteins with ND10 is not exclusive to the
IE proteins IE1 and IE2. The viral tegument protein and transactivator
pp71 likewise accumulates at ND10 immediately upon HCMV
infection and before the production of IE proteins [122–124]. Direct
binding to the ND10 component hDaxx has been shown to be
responsible for the targeting of pp71 to PML-NBs [122,123]. Interest-
ingly, abolishing pp71's ability to interact with hDaxx blocks pp71's
localization at ND10 and inhibits pp71's ability to transactivate the
major immediate early promoter (MIEP) of HCMV [122,123,125],
indicating that the association of pp71 with hDaxx in ND10 is critical
for its function as a facilitator of IE gene expression at the very start of
a lytic infection. Although initial studies implied that pp71 and hDaxx
associate at ND10 to cooperatively activate the MIEP [122], it is now
clear from multiple subsequent work that hDaxx actually silences the
MIEP, and that pp71 relieves this repression [126–130]. Consistent
with this assumption, overexpression of the cellular restriction factor
hDaxx abolishes HCMV infection while down-regulation of hDaxx by
usage of small interfering RNA (siRNA) technology, on the contrary,
results in increased gene expression and virus replication [126–130].
The hDaxx-mediated repression of viral IE gene expression correlates
with changes of the chromatin structure around the MIEP as
knockdown of hDaxx results in loss of transcriptionally-repressive
and gain of transcriptionally active chromatin at the MIEP [126]. This
regulation appears to involve histone deacetylases, since treatment of
infected cells with HDAC-inhibitors relieves the repression of viral IE
gene expression [126,127].
In order to successfully antagonize hDaxx-mediated intrinsic
immune defense, tegument-delivered pp71 induces the degradation
of hDaxx at the start of a lytic infection [127,130], which has been
postulated to occur in a proteasome-dependent [127] and ubiquitin-
independent manner [131]. Inhibiting the proteasome at the time of
infection, however, still suppresses viral IE gene expression even in
the absence of hDaxx, suggesting the existence of additional antiviral
targets for proteasomal degradation [132]. Consistent with a function
of pp71 in counteracting the repressive effect of hDaxx, HCMV
inefﬁciently enters productive infection in the absence of pp71
[125,133], unless hDaxx protein levels are depleted prior to infection,
thus annihilating the impaired growth phenotype associated with a
pp71-deﬁcient mutant [128–130]. Failure of pp71 to overcome hDaxx
repression blocks viral IE gene expression and may promote the
establishment of latent HCMV infections [134]. However, whether
hDaxx is a major factor contributing to the control of HCMV latency is
still controversially discussed [134,135].
In summary, these data clearly identiﬁed hDaxx, like PML, as a
cellular restriction factor being responsible for silencing of HCMV IE
gene expression directly upon infection. Moreover, since knockdown
of hDaxx in combination with PML led to a further increase in the
replication efﬁcacy of HCMV, this strongly argues for an independent
involvement of both ND10 factors in the restriction of viral infection
and gives rise to the following working model: Immediately after
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to induce a repressive chromatin structure via epigenetic modiﬁca-
tions resulting in transcriptionally inactive viral genomes (see Fig. 1A
and B). As a ﬁrst line of defense, the imported HCMV structural protein
pp71 antagonizes hDaxx-mediated gene silencing by inducing the
proteasomal degradation of hDaxx (Fig. 1B-1). The relief of hDaxx-
mediated repression, then, allows the initiation of IE gene expression
(Fig. 1B-2). The synthesis and accumulation of IE1 at ND10, in a next
step, efﬁciently overcomes PML-mediated repression by inducing the
disruption of this subnuclear structure thereby ensuring the initiation
of an efﬁcient lytic replication (Fig. 1B-3). In case pp71 is sequestered
in the cytoplasm of infected cells, as postulated for cells in which
latent-like HCMV infections are established [134], input viral genomes
are likewise targeted by ND10 (Fig. 1A). However, the repressive effect
of hDaxx on viral gene expression is not relieved as pp71 fails to enter
the nucleus and to degrade hDaxx (Fig. 1A). As a consequence of this,
the viral genomes remain in a transcriptionally repressed quiescent
state (Fig. 1A).
Interestingly, recent unpublished observations of our group
indicate that, comparable to the situation in PML- and hDaxx-kd
cells, ablation of Sp100 also leads to a considerable increase in the
number of IE protein-positive cells, suggesting that Sp100 likewise
contributes to ND10-mediated viral repression. Overall, these data
support a model in which, comparable to HSV-1 infection, individual
ND10 components function in counteracting the initiation of an
efﬁcient productive viral replication. This further underlines the
notion of ND10 as mediators of an intrinsic immune defense against
herpesvirus infections in general.
5.3. Epstein–Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus
(KSHV), and murine gamma-herpesvirus 68 (MHV-68)
In common with all herpesviruses, EBV from the γ-herpesvirus
subfamily, possesses a biphasic life cycle consisting of a lytic and a
latent phase. However, in contrast to HSV-1, its latent state is
characterized by the expression of a set of proteins that are necessary
for establishment and maintenance of latency [94]. While during
latency, EBV genomes can be found in close association with
interphase chromosomes, activation of the lytic replication cycle
results in a spatial redistribution of viral DNA to ND10 [136]. Using in
situ hybridization the authors also showed the development of
replication centers starting at ND10 as replicating EBV genomes were
frequently found beside this nuclear domain [136]. Subsequent
studies identiﬁed the orilyt sequence as being required for the
appearance of replicating episomes in association with PML-NBs
[137]. However, the integrity of ND10 is no longer maintained as soon
as productive EBV infection is initiated. The expression of lytic
proteins is accompanied by a sequential redistribution of ND10
proteins starting with the dispersal of Sp100, hDaxx, and NDP55
which is then ﬁnally followed by PML relocalization [136–138].
Induction of productive EBV replication goes along with the
expression of BZLF-1, the principal inducer of the lytic gene
expression program [94]. Indeed, experiments carried out by
Adamson and Kenney [138] illustrated, that BZLF-1 expression is
sufﬁcient to induce ND10 disruption by reducing the level of
SUMOylated PML. BZLF-1, which is itself SUMO-1 modiﬁed, has
been shown to compete with PML for limiting amounts of SUMO-1
[138]. In accordance with this, mutation of the SUMO-modiﬁcation
site of BZLF-1 abrogates desumoylation of PML [138]. However, this
does not annihilate the capability of BZLF-1 to disperse ND10 after
transient expression suggesting the existence of additional mechan-
isms for BZLF-1-mediated ND10 disruption. Further mutational
analysis of BZLF-1 revealed a correlation between the capability of
this protein to disperse Sp100 from ND10 and its efﬁciency to
activate transcription via interaction with the ND10-located factor
CBP [139].Although initial studies suggested that EBV infection has no
inﬂuence on ND10 during latency [136], recent evidence indicates that
the latently expressed protein EBNA-LP (also designated as EBNA5) is
likewise modifying the composition of ND10 accumulations. Already
over ten years ago, EBNA-LP, which is important for EBV-mediated B-
cell immortalization by functioning as a potent gene-speciﬁc
coactivator of the viral transcriptional activator EBNA2 [140], was
reported to colocalize with ND10 in EBV-positive lymphoblastoid cell
lines [141]. Novel ﬁndings imply that EBNA-LP coactivates EBNA2
through binding of the ND10 factor Sp100, thereby selectively
displacing it together with HP1α from PML-NBs [142]. Since both
HP1α and Sp100 have been shown to possess transcriptional
repressor activity [41,42,143], and expression of a mutant form of
Sp100, that was unable to associate with ND10, resulted in coactiva-
tion of EBNA2 even in the absence of EBNA-LP [142], it has been
speculated that the EBNA-LP-induced ND10 rearrangements may
mitigate transcriptional barriers that prevent efﬁcient expression of
viral latent genes important for establishing latency. In summary,
these results were regarded as the ﬁrst indication that modulation of
ND10 might also be required for establishment of nonproductive or
latent herpesvirus infections.
Human herpesvirus 8 (HHV8), a γ-herpesvirus also known as
Kaposi's sarcoma-associated herpesvirus (KSHV), is a lymphotropic
virus involved in the pathogenesis of Kaposi's sarcoma (KS), primary
effusion lymphoma (PEL), and a subset of multicentric Castleman's
disease (MCDs). KSHV also encodes an early protein, K8, which is a
distant evolutionary homologue of the EBV regulatory factor BZLF-1,
that has been found to localize to ND10 and to establish replication
compartments in associationwith this nuclear substructure [144,145].
However, unlike BZLF-1, K8 does not induce any changes to ND10
composition [145]. Consequently, the genome replication of KSHV
occurs in close contact to intact PML-NBs [144]. Taken together, these
data support the notion that it may be a general feature of
herpesviruses to initiate their replication in the vicinity of ND10
structures.
MHV-68, which, like KSHV, belongs to the herpesvirus genus
rhadinovirus, is emerging as a suitable model to study basic biological
questions of gamma-herpesvirus host interactions due to the fact that
it naturally infects mice. Intriguingly, data from our group as well as
from others suggest that MHV-68 infection also affects ND10 (N.
Tavalai, F. Full, A. Ensser and T. Stamminger, unpublished) [146]. As
determined by Western blot (Fig. 2A) as well as immunoﬂuorescence
analysis (data not shown), MHV-68 completely eliminates PML upon
infection of primary human ﬁbroblasts in order to annihilate the
antiviral activity of ND10. The complete loss of PML as a consequence
of MHV-68 infection presumably accounts for the simultaneously
observed disappearance of the SUMO-modiﬁed forms of Sp100 (Fig.
2B), comparable to the situation in HSV-1 infected cells (see 5.1.) or
after depletion of the deﬁning ND10 factor in PML-kd HFFs [13]. At the
same time, MHV-68 also induces a signiﬁcant reduction in hDaxx
protein levels when compared to mock-infected cells (Fig. 2C).
Although this effect on hDaxx is much less pronounced in comparison
toMHV-68 mediated PML downregulation, it nevertheless mimics the
ﬁndings for HCMV, where we were likewise never able to detect a
total depletion of the transcriptional repressor hDaxx during the
HCMV replicative cycle [130]. Thus, MHV-68 could constitute the ﬁrst
virus that negatively affects the abundance of all three major ND10
constituents directly upon infection in order to efﬁciently circumvent
the intrinsic antiviral response instituted by ND10.
5.4. Adenoviruses
Adenoviruses (Ad) are a family of non-enveloped, nuclear-
replicating DNA viruses that comprise more than 50 different
human serotypes causing a variety of distinct pathologies ranging
from respiratory disease and conjunctivitis to gastroenteritis.
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studied subtype, results in a redistribution of ND10 into characteristic
elongated tracks during the early hours after virus inoculation
[147,148]. By using a variety of Ad5 mutants, the early protein E4
ORF3 could be identiﬁed as being necessary to execute the
rearrangement of ND10 from punctate bodies into these track-like
structures [147,148]. Moreover, exogenous expression of E4 ORF3
alone was shown to be sufﬁcient for this effect and the localization of
E4 ORF3 in these structures [147,148]. The E4 ORF3-dependent tracks
contain the known ND10 proteins, all of which, except for PML, are
later recruited into viral replication compartments [82]. However, the
physiological signiﬁcance of the selective incorporation of ND10
factors like Sp100 or NDP55 into viral replication sites still remains
unclear. Furthermore, infection studies using the E4 ORF3 deletion
virus in order to retain intact PML-NBs demonstrated that Ad
replication domains, like in case of herpesviruses, would normally
be located directly adjacent to ND10 [82]. By monitoring the fate of
input wt Ad genomes, a preferential association with this subnuclear
structure prior to ND10 disruption and the start of viral DNA
replication was observed similar to that seen for various other
nuclear-replicating DNA viruses which has also been found to occur
independent of viral gene expression comparable to the situationwith
HSV-1 [82].
Beside its role in redistributing ND10 components, E4 ORF3, in
addition, functions in antagonizing the cellular Mre11-Rad50-Nbs1
(MRN)-dependent DNA damage response that is induced by adeno-
viral genomes during infection. Activation of the MRN DNA repair
complex would otherwise lead to concatemerization of viral genomes
and the efﬁcient prevention of viral DNA replication [149]. To impede
this host response, E4 ORF3 contributes to the inhibition of MRN
function by sequestering the nucleoplasmic pool of MRN proteins into
the E4 ORF3-containing track-like structures [150–153]. Mutational
analyses have demonstrated that PML and MRN reorganization of E4
ORF3 are discrete activities of the protein [153]. While MRN
relocalization by E4 ORF3 is speciﬁc to only a subset of Ads, the
ability of E4 ORF3 to rearrange ND10 was found to be evolutionarily
conserved among divergent serotypes, further underlining the
signiﬁcance of this phenomenon [151]. Only recently, the functional
consequences of E4 ORF3-mediated ND10 track formation have been
elucidated in greater detail: Ullman and colleagues [154,155] could
show that E4 ORF3 successfully antagonizes an IFN-induced antiviral
state mounted by ND10 via disrupting this subnuclear structure early
during infection.While pretreatment of cells with INF-α or INF-γ does
not prevent E4 ORF3 elicited ND10 rearrangement upon wt Ad
infection despite the increased synthesis of individual ND10 compo-
nents, replication of an E4 ORF3 deletion virus, on the contrary, is
efﬁciently restricted under these conditions [154,155]. In accordance
with this, reduction of either PML or hDaxx (but not Sp100) by shRNAs
turned out to be sufﬁcient to restore the replicative capacity of the E4
ORF3-deﬁcient Ad following IFN stimulation of cells [155]. On the
other hand, infection of cell lines, engineered to overexpress PML
(isoform VI), block or severely delay adenovirus replication [148].Fig. 1. Schematic representation of the current model of HCMV-ND10 interplay during
infection. (A) In cells in which quiescent HCMV infections are established, it is
speculated that pp71 is somehow retained in the cytoplasmwhile incoming viral DNA is
efﬁciently targeted by ND10. By this, pp71 is prevented from binding to and degrading
the restriction factor hDaxx. As a consequence of this, hDaxx-induced epigenetic gene
silencing is not abrogated resulting in transcriptionally repressed viral genomes that are
unable to initiate the lytic gene expression program of HCMV. (B-1) In cells permitting
productive HCMV infection, pp71 is capable of entering the cell nucleus and targeting
hDaxx for proteasome-dependent destruction. (B-2) pp71-induced reduction of hDaxx
protein levels annihilates the repressive effect of hDaxx on the viral chromatin leading
to the initiation of viral IE gene expression and production of the regulatory protein IE1.
(B-3) Upon entry of the nucleus, IE1 localizes to ND10 to ﬁnally induce the disruption of
this subnuclear structure. ND10 dispersal by IE1 correlates with the induction of an
efﬁcient lytic replication.
Fig. 2. Examination of the protein levels of the three major ND10 constituents PML, Sp100, and hDaxx upon MHV-68 infection. HFFs were either mock infected (lane 1) or infected
with MHV-68 (lane 2) and lysates were harvested 24 h postinoculation to be subjected toWestern blotting. (A) The various SUMOylated as well as non-SUMOylated isoforms of PML
were detected with the anti-PML rabbit serum H-238 (Santa Cruz). The major PML isoform is indicated by an arrow. (B) Sp100 protein levels were assayed using the anti-Sp100
polyclonal antibody AB1380 (Chemicon). The different variants of Sp100 are speciﬁed by arrows. (C) Analysis of hDaxx abundance was achieved with an anti-hDaxx monoclonal
rabbit antibody from Epitomics. Actin was included as an internal loading control.
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the IFN-induced antiviral response against Ad which is normally
counteracted by the E4 ORF3 protein. However, in contradiction to
ﬁndings from herpesviruses like HSV-1 (see 5.1.) or HCMV (see 5.2.),
the antiviral strategy of ND10 in case of Ad infection is not solely based
on transcriptional repression since Ad early gene expression is only
modestly affected to a degree that is not sufﬁcient to compromise
early protein function [155]. Instead, it was reported that PML-NBs
mainly suppress Ad infection by negatively inﬂuencing viral DNA
replication [154,155]. Therefore, the authors propose that, in addition
to its abilities to repress gene expression, ND10 participate in
additional innate immune defense activities.
In this regard, it is of note that the replication defect of the E4 ORF3
mutant virus upon interferon treatment could be restored by co-
expression of either ICP0 or IE1 [155], the herpesvirus regulatory
proteins known to successfully evade ND10 repression during HSV-1
(see 5.1.) and HCMV replication (see 5.2.), respectively. Thus, these
data suggest that Ad E4 ORF3, HSV-1 ICP0, and HCMV IE1 behave in a
functionally analogous manner with respect to antagonizing the
antiviral role of ND10 as they share in common the ability to disrupt
ND10 integrity albeit employing mechanistically distinct strategies to
achieve this purpose.
The exact mechanism by which E4 ORF3 causes ND10 dispersal is
still unclear. While transiently expressed E4 ORF3 has been shown to
have no effect on the SUMOylation state of exogenous PML (isoform
IV) [89], Ad infection results in a gradual loss of the high molecular
weight SUMO-modiﬁed variants of PML [156]. In addition, the
appearance of novel, infection-speciﬁc species of PML was observed,
one of which became predominant later in the infectious course [156].
Since these effects on PML occur in an E4 ORF3-dependent manner
[156], it is likely that they are related to the E4 ORF3-mediated
changes in ND10 structure taking place during infection although
direct evidence for this assumption is still missing. Consequently, in
order to affect the PML modiﬁcation status, E4 ORF3 either requires
additional infection speciﬁc factors or a PML isoform other than PML-
IV is the major target for the induction of ND10 track formation.
Indeed, recent studies indicate that particularly the interaction of E4
ORF3 with PML isoform II seems to be required for ND10 disruption
[157]. Moreover, the observation that the overall pattern of PML
isoforms in Ad-infected cells is very reminiscent of the pattern seen in
cells during mitosis when ND10 are temporarily dispersed [18], gave
rise to following ideas: (i) The Ad-induced effect on ND10 could be an
indirect consequence of changes to cell cycle regulation imposed upon
infection. (ii) Ad simply utilizes relatedmolecular triggers that are also
used during cell cycle regulation to achieve similar changes of the PML
modiﬁcation pattern.Of interest, during the late phase of the infection cycle an Ad
structural protein, known as the minor capsid protein IX (pIX), has
been implicated in maintaining the E4 ORF3-initiated neutralization
of ND10. Rosa-Calatrava et al. [158] could demonstrate that pIX
expression induces the formation of speciﬁc nuclear structures known
as clear amorphous inclusions and the stable recruitment of ND10
components like PML and Sp100 into these structures at late times of
infection in order to prevent ND10 re-formation [159]. These data
imply that Ad has evolved a unique strategy to sustain the inactivation
of ND10 throughout infection, thereby ensuring optimal viral replica-
tion. Intriguingly, infection with a mutant virus that lacks expression
of the ﬁbre protein, which normally builds up the spikes at the vertices
of the virion, results in accumulation of other major capsid proteins
like the viral hexon and penton base proteins, in these amorphous
nuclear inclusions [160]. Although the concrete signiﬁcance of this
ﬁnding is uncertain, it could provide a ﬁrst indication that Ad virion
assembly might also be linked to ND10.
5.5. Papillomaviruses
Human papillomaviruses (HPV) comprise a heterogeneous group
of non-enveloped, small DNA viruses that induce benign epithelial
papillomas and have been implicated etiologically in human cervical
carcinoma, as well as in a subset of other epithelial carcinomas [94].
HPV infections are characterized by a biphasic life cycle which is
tightly linked to the differentiation process of the host squamous
epithelia. Nonproductive infection initiates and is maintained in the
basal cell layers of the epithelium. In these undifferentiated,
mitotically active cells, a subset of viral genes called the early genes,
are expressed and the viral DNA is replicated on average once per cell
cycle and efﬁciently segregated to daughter cells. Upon terminal
differentiation of keratinocytes the productive life cycle of HPV is
induced, resulting in viral DNA ampliﬁcation, structural protein
expression, and progeny virus assembly [94].
The ﬁrst report relating papillomavirus infection to ND10 came
from Day et al. [161] showing that the minor capsid protein L2 from
bovine papillomavirus type 1 (BPV1) colocalized with this subnuclear
structure when exogenously expressed. This observation could
subsequently be conﬁrmed using the L2 protein from human
papillomavirus type 16 (HPV16) [162]. In addition, L2 turned out to
be responsible for the redistribution of the major capsid protein L1 as
well as the nonstructural protein E2 to ND10 upon co-expression
[161]. Analysis of L2 fromHPV33, furthermore, revealed an L2-induced
reorganization of ND10-asssociated proteins: while the major struc-
tural component PML remained unaffected, Sp100 protein levels were
found to be signiﬁcantly reduced upon L2 expression [163]. On the
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presence of L2 and both proteins were shown to interact with each
other, either directly or via an intermediate [163] which was
suggested to be the driving force for L2 accumulation at ND10 [164].
Continuative experiments revealed that L2 aggregation at ND10
precedes that of L1, as the major capsid protein only arrives at these
nuclear foci after L2-induced release of the ND10 factor Sp100 [165].
Given the fact that the E2 protein speciﬁcally binds to the viral DNA
[166], this suggested that also viral genomes are deposited at ND10
through L2-mediated recruitment of E2 to these subnuclear sites, thus
proposing a model in which ND10 serves as a place for encapsidation
of the viral DNA. The changes to ND10 composition as a consequence
of L2 expression could facilitate packaging of the newly synthesized
virions at PML-NBs. However, recent ﬁndings indicate that ND10
structures are absent in the terminally differentiated layers of the
stratiﬁed epithelium, the sites of papillomavirus progeny virion
assembly, as determined in organotypic raft cultures of human
keratinocytes harboring HPV genomes, which support the differentia-
tion-dependent life cycle of HPV [167]. These data ﬁt to the previous
observation that L2 still assembles in distinct foci and recruits L1 to
these sites to form virus-like particles even in the absence of genuine
ND10 as assessed in PML-null ﬁbroblasts [168]. Interestingly, similar
to the results obtained for the hepresviruses HSV-1 (see 5.1.) and
HCMV (see 5.2.), these L2 aggregates still attracted the transcriptional
repressor hDaxx, which is normally diffusely distributed upon loss of
the deﬁning ND10 component [168]. Moreover, localization studies of
L2 from HPV16 conducted under physiologically more relevant
conditions demonstrated that the ability of L2 to accumulate at
ND10 is dependent on the protein expression level as well as the
presence of other heterologous viral factors [169]. In contrast to the
former reports in which viral overexpression systems such as Semliki
Forest virus or vaccinia virus were employed to dissect the
intracellular distribution of L2 [161,163], the minor capsid protein
only rarely localized at ND10 under moderate expression conditions if
a codon-optimized version of L2 was used [169]. These results led the
authors to conclude that L2 does not actively accumulate in ND10, but
that ND10 location of L2 rather seems to be triggered by additional
cellular factors which are induced, potentially as an antiviral defense
mechanism.
In a transient replication assay the subnuclear topology of HPV11
ori DNA replication was characterized in more detail [170]. As judged
by indirect immunoﬂuorescence analysis, papillomaviral DNA ampli-
ﬁcation may also be coupled to ND10 [170]. The early proteins E1 and
E2, which are involved in viral DNA replication, are known to interact
and to bind together to the papillomavirus origin of replication [94].
While E2 was reported to be recruited to ND10 by L2 upon
coexpression, E1 was not [161]. Both, E1 and E2 of HPV11, however,
were found to accumulate at PML-NBs if expressed together in the
presence of papillomavirus replication origin-containing plasmid DNA
[170]. When the ori plasmid was omitted from the transfection, PML
was still found to colocalize with E1 or E2, but at a much reduced
frequency, suggesting that the degree of ND10 localization was
inﬂuenced by active HPV DNA synthesis [170]. However, in a study
conducted by Nakahara and Lambert et al. [167] it was demonstrated
that PML and ND10 are not required for papillomavirus DNA
replication in transfected cells. Nevertheless, these data imply that
HPV replication compartments, as in case of other DNA viruses, are
established in close proximity to ND10 but without having an impact
on the integrity of this subnuclear structure.
In contrast to that, Roberts et al. [171] identiﬁed a late infection
phase product, the E4 protein of HPV1, which is capable of modifying
ND10 organization. Over-expression of the E4 protein results in the
formation of nuclear inclusions [172]. Although the precise nature of
the E4-derived inclusion bodies is not known, E4 induces the
relocation of PML from ND10 to the periphery of these subnuclear
structures [171]. Analysis of HPV1-induced warts demonstrated thatsimilar nuclear PML-E4 inclusions were also present in productively
infected keratinocytes [171]. Consequently, it was concluded that
reorganization of PML occurs not only in vitro but also in vivo. Since E4
expression correlates with the onset of vegetative genome replication
in naturally occurring lesions including those induced by HPV1, the
authors suggested that the E4-induced reorganization of PML
represents a switch in the HPV life cycle, from the nonproductive
maintenance stage of replication in the basal cells to the virus-
producing productive phase in differentiating cells. Given the
emerging link between ND10 and viral genome replication, the E4-
mediated redistribution of ND10 could be necessary for efﬁcient
replication of the virus during the productive phase.
Previous reports have also linked the early papillomavirus proteins
E6 and E7 to ND10. Both viral proteins are known to possess oncogenic
properties by predominantly targeting p53 (E6) and pRB (E7) for
inactivation. While E6 and E7 from high-risk virus types (HPV16 or
HPV18) display a diffuse distribution pattern throughout the nucleus,
the equivalent oncoproteins expressed from a low-risk virus type
(HPV11), on the contrary, were found to form punctate accumulations
in associationwith PML [173]. In addition, the E7 proteinwas shown to
inhibit PML isoform IV-induced senescence due to its ability to
simultaneously disrupt pRb, p53/CBP, and PML functionality through
direct interaction [174]. Normally, PML concomitantly activates the
p53 as well as pRb tumor suppressor pathway to ensure complete
drop out from the cell cycle. Similarly, also the E6 protein counteracts
PML-mediated cellular senescence by speciﬁcally destabilizing PML
isoform IV in a proteasome-dependent pathway [175]. Overall, it is
tempting to speculate that the fundamental differences in ND10/PML
interaction of the high- and low-risk E6 and E7 proteins contribute to
the differences in oncogenicity and pathogenicity of the diverse
papillomavirus subtypes.
Recent investigation of the trafﬁcking of papillomavirus particles in
infected cells revealed that DNA encapsidated in papillomavirus
pseudovirions together with the minor capsid protein L2 associated
with ND10 directly upon nuclear entry and prior to the start of DNA
ampliﬁcation [176]. Thus, in the meantime quite a series of data exist
that connect ND10 with all stages of the papillomavirus life cycle.
Initial functional studies conducted to address the biological relevance
of ND10 for papillomavirus replication indicate that, in contradiction
to the ﬁndings for HSV-1 (see 5.1.), HCMV (see 5.2.), or adenoviruses
(see 5.4.), ND10 seem to positively affect papillomavirus infectivity
[176]. The presence of PML and intact ND10 is associated with
enhanced papillomaviral early gene expression [176]. However, it has
to be emphasized that the efﬁciency of viral transcription as measured
in the absence of PML and putative ND10 was compared to the
transcriptional activity obtained after infection of PML-null MEFs
which were stably transduced with PML isoform III only [176]. Given
the accumulating evidence that PML cannot be considered as a single
protein with the different variants having distinct properties and
activities [16,177], and viruses speciﬁcally targeting particular iso-
forms for ND10 destruction only (e.g. see adenoviruses 5.4.) [157], it
has to be questioned if reintroduction of other PML isoforms or usage
of wt MEFs would yield similar results. Moreover, by performing a
luciferase reporter gene assay another group foundno difference in the
efﬁcacy of E2-mediated viral transcription in PML−/− versus PML+/+
cells [167]. Thus, the functional role of ND10 structures for papillo-
mavirus infection is still controversially discussed and awaits further
examination.
5.6. Polyomaviruses
In common with all other nuclear-replicating DNA viruses, input
viral genomes of the simian polyomavirus SV40 have been found to
localize preferentially to ND10 and start to replicate adjacent to these
subnuclear sites but without noticeable modiﬁcation of ND10 [82].
Subsequent experiments revealed that the replicative process also
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cells, indicating that none of the capsid proteins is necessary for this
activity [178]. However, plasmid replicons bearing a reporter gene
only localized to or nearby to ND10 when they contained the SV40
origin of DNA replication in the presence of SV40 large T antigen,
which is essential for SV40 DNA replication [178]. Detailed analysis
indicated that the large T-antigen binding site II (the core origin) was
sufﬁcient for large T-induced DNA ampliﬁcation at ND10 [178].
Furthermore, sequestration of DNA molecules to these structures
appears to require active viral DNA synthesis [179]. Interestingly, a
signiﬁcant proportion of the viral DNA positioned at ND10 was found
to be single-stranded implying that viral genome replication at ND10
could be induced by ND10-associated DNA repair mechanisms [179].
While depletion of PML had no signiﬁcant effect on the overall efﬁcacy
of viral DNA replication, it completely abolished the accumulation of
single-stranded DNA in nuclear foci [179].
In addition, reporter gene transcription was also detectable at
ND10 but equivalent levels of expression were also observed from
plasmid DNA which was not located at this subnuclear site and with
transcripts being diffusely distributed throughout the nucleoplasm
[178]. Although plasmid transcription can take place anywhere in the
nucleus, T-antigen-directed replication is apparently restricted to
ND10. These ﬁndings suggest that viral transcription at ND10 may
only be a consequence of viral genome ampliﬁcation at this domain.
However, these data are in apparent conﬂict to results obtained by
Bishop et al. [180], showing that plasmid DNA delivered by
polyomavirus-like particles associated with ND10 even in the absence
of SV40 large T-antigen and ori sequences. In the latter case,
colocalization of virus like particle-delivered transgenes with PML-
NBs was reported to be a consequence of transgene expression rather
than the presence of speciﬁc viral replication factors as activation of
transcription resulted in relocation of foreign DNA from transcrip-
tionally inactive centromeric heterochromatin to ND10 and regions of
transcriptionally active euchromatin [180]. The same study provided
evidence that the association of foreign DNA with ND10 does not
inﬂuence transgene expression per se, but that the PML protein is
necessary for the α-IFN-mediated inhibition of foreign gene tran-
scription [180]. This further strengthens the assumption that viral
localization at ND10 is not for the beneﬁt of the virus but rather
represents a host-regulated process which is part of an inducible
cellular defense mechanism.
Finally, comparable to adeno- (see 5.4.) or papillomavirus infection
(see 5.5.), ﬁrst evidence exists that also polyomavirus virion assembly
is related to ND10. As reported for the human polyomavirus JC (JCV),
transient co-expression of the major (VP1) as well as the minor capsid
proteins (VP2 and VP3) along with a regulatory protein called
agnoprotein resulted in cooperative accumulation of these viral
components and assembly of virus-like particles in discrete nuclear
domains which were identiﬁed as ND10 [181]. Similar nuclear foci
were detected in oligodendrocytes isolated from human brain tissue
of autopsied patients with progressive multifocal leukoencephalo-
pathy what further underlines the physiological signiﬁcance of this
ﬁnding [181]. Intriguingly, recent data indicate that progression of
viral progeny production at ND10 ﬁnally leads to the disruption of this
subnuclear structure [182]. JCV-induced destruction of ND10 can
presumably be regarded as the trigger for oligodendrocyte degenera-
tion and the resulting demyelination, the hallmarks of progressive
multifocal leukoencephalopathy [182].
6. RNA viruses and ND10
As speciﬁed in detail in the prior chapters, replication of quite a
variety of DNA viruses that enter the nucleus as part of their
replicative cycle has been found to be intimately connected to the
subnuclear structure ND10. Even more surprisingly, evidence is
accumulating that also infection of an increasing number of RNAviruses from several different families is affected by ND10. The current
state of knowledge concerning RNA virus replication and ND10 is
brieﬂy discussed below.
6.1. Retroviruses
Retroviruses are characterized by their unique infection strategy,
as their RNA genomes are initially reverse transcribed into DNA to be
subsequently integrated into the host chromosome. Meanwhile, the
infectious cycle of viruses from four different genera of the retrovirus
family has been shown to be related to PML and ND10.
Exogenous expression of PML isoform III, for instance, was
reported to confer resistance against human foamy virus (HFV), a
complex retrovirus, as a substantial decrease in HFVmRNA expression
levels, DNA and protein synthesis as well as reverse transcriptase
activity is detectable [183]. The mechanism of this effect appears to
involve the PML-induced complex formation with the viral transacti-
vator Tas, thereby preventing Tas from binding to viral promoter
sequences and activating viral gene expression [183]. Interestingly,
HFV infection could similarly be compromised by treatment of cells
with IFN. Since IFN application resulted in restriction of HFV
replication in wt but not in PML−/− MEFs, this points to a role for
PML in the IFN-mediated antiviral action against HFV [183]. However,
PML seems not to be involved in the establishment of HFV latency
[184]. Thus, the biological signiﬁcance of PML-mediated suppression
of HFV replication is still unclear.
The human T-cell leukemia virus type 1 (HTLV-1) encodes a
transcriptional activator, the Tax protein, which promotes cellular
transformation and is associated with the pathogenesis of adult T-cell
leukemia [94]. The Tax oncoprotein has been demonstrated to alter
the subcellular localization of an ND10-associated protein known as
Int-6. Tax directly interacts with Int-6, as determined by yeast and
mammalian two-hybrid analysis as well as co-immunoprecipitation
and induces Int-6 redistribution from ND10 to the cytoplasm without
affecting the localization of PML [185]. In addition, Taxwas found to be
a potent repressor of steroid and retinoid receptor transcription [186].
However, the repressive effect of Tax can be reversed by over-
expression of PML [186], suggesting that the modulation of ND10
composition by Tax is of functional signiﬁcance.
Also, infection with human immunodeﬁciency virus type 1 (HIV-
1), the causative agent of AIDS, was shown to affect ND10morphology
upon infection as incoming retroviral preintegration complexes
trigger the cytoplasmic export of the key factor PML [187]. Nuclear
redistribution of PML to ND10 as achieved via treatment with arsenic
trioxide resulted in an increased transduction efﬁciency of HIV,
suggesting that PML is acting as part of an antiviral response by
opposing the establishment of infection. However, other groups failed
to conﬁrm these results as they were not able to observe a
colocalization of viral preintegration complexes with PML [188,189].
In addition, further experiments revealed that PML is dispensable for
the stimulatory effect of arsenic trioxide on HIV-1 replication [189].
Thus, the role of PML and ND10 for HIV-1 remains uncertain.
Finally, during avian sarcoma virus (ASV) infection an interaction
of the ND10 constituent hDaxx with the retrovirus integrase (IN) as
well as the reverse transcribed viral DNA is detectable [190]. The
association of hDaxx with the retroviral DNA turned out to induce a
silencing of ASV gene expression presumably via recruitment of
HDACs to the viral genome [190]. By the usage of an siRNA-based
approach, the involvement of hDaxx and HDAC in the epigenetic gene
silencing of integrated retroviral DNA could be conﬁrmed, as knock-
down of both host factors annihilated transcriptional repression of a
reporter gene construct [191]. These experiments furthermore
indicated that hDaxx/HDAC-mediated gene silencing is largely
independent of the integration site of the DNA or the type of promoter
used for reporter gene expression [191], suggesting that hDaxx/HDAC
functions in a fairly broad and unspeciﬁc manner against integrated
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pp71 (see 5.2.), for instance, with its well-established function in
counteracting hDaxx antiviral activity, indeed, resulted in reactivation
of reporter gene transcription [191]. In summary, these data further
support the evolving concept of hDaxx as being part of an antiviral
defense mechanism of the cell.
6.2. Other RNA viruses
Presumably the most convincing data in order to clarify the in vivo
relevance of ND10 for viral infection have been obtained with RNA
viruses like the arenavirus lymphocytic choriomeningitis virus
(LCMV) or the rhabdovirus vesicular stomatitis virus (VSV), which
are studied as model systems in mice. Examination of the functional
role of ND10 structures in vivo revealed that PML deﬁciency renders
micemore susceptible to LCMV and VSV infections [192]. These in vivo
observations corroborate previous ﬁndings demonstrating that
ﬁbroblasts derived from PML−/−mice support enhanced LCMV growth
[193] and are alsomore sensitive thanwtMEFs to infectionwith rabies
virus, another member of the rhabdovirus family [194]. Furthermore,
increased expression of PML as a consequence of IFN treatment of cells
[193] or stable transfection with a construct encoding PML isoform III
[195], turned out to be capable of diminishing LCMV [193] and VSV
replication [195], respectively, due to a decrease in viral mRNA and
protein production. In addition, the capacity of IFN to guard against
LCMV infection has been shown to be higher in wt MEFs compared to
PML-null MEFs, although LCMV production is still diminished in IFN-
treated PML−/−MEFs, indicating that the IFN sensitivity of LCMV is not
entirely based on PML [193]. Thus, these results implicate PML in an
intrinsic antiviral response of the cell that targets not only DNAviruses
but also divers cytoplasmic replicating RNA viruses.
Interestingly, comparable to the situation with DNA viruses, some
RNA viruses, for which the infectious cycle is inhibited by PML, have
developed strategies to compromise ND10 composition to various
extents. LCMV, for instance, was found to disrupt ND10 during
infection due to the action of a small non-structural protein called Z
[196]. The RING-ﬁnger protein Z colocalizes with PML both in
transfected as well as infected cells and induces the redistribution of
PML from nuclear ND10 bodies into the cytoplasm of cells [196],
where both proteins directly interact with the elongation factor eIF4E,
thereby reducing its afﬁnity for the 5′ mRNA cap structure and
inhibiting translation [197]. Similarly, the phosphoprotein P of rabies
virus also binds to PML and causes its relocation into the cytoplasm
[194]. Following rabies virus infection, however, PML delocalization
could not be observed. Instead, PML-containing ND10 structures
increase in size as likewise detected upon transfection of P3, an N-
terminally truncated version of the phosphoprotein P, which is
therefore believed to be responsible for this effect [194].
Finally, three viral proteins of the orthomyxovirus inﬂuenza A,
have been shown to associate with PML and ND10 during infection,
namely the matrix protein M1, as well as the nonstructural
polypeptides NS1 and NS2 [198]. Although, the functional signiﬁcance
of this ﬁnding is still unclear, previous studies demonstrated that
propagation of inﬂuenza A virus is likewise negatively inﬂuenced by
PML as productive infection could be signiﬁcantly suppressed by
overexpression of PML isoforms III, IV as well as VI [195,199]. In
accordance with this, downregulation of PML expression by RNAi, on
the other hand, enhanced viral replication [199]. Thus, these data
support the notion that PML also contributes to the countermeasures
the cell has evolved against inﬂuenza A virus infection.
7. Concluding remarks
ND10 have been identiﬁed as preferential targets for viral
modiﬁcation by members of both DNA as well as RNA viral families.
But why do viruses with such diverse replication strategies interactwith and commonly alter ND10 accumulations during their replicative
cycle? In principle, two theories have been established that try to
explain the reason for the intimate virus interactions with ND10.
Firstly, ND10 could harbor components or provide functions that are
advantageous for the virus and support viral replication. Alternatively,
ND10 structures could illustrate aggregations of proteins that
compromise virus growth and which are therefore targeted by the
virus for destruction to be inactivated.
In this review we summarized the rapidly growing body of
information thatmainly links ND10 to an antiviral defensemechanism
of the cell that has evolved to efﬁciently counteract infection of quite a
variety of distinct viruses. Evidence continues to accumulate that
basically all three major ND10 components, PML, Sp100, as well as
hDaxx constitute host factors with antiviral activities as supported by
work on herpesviruses like HSV-1 (see 5.1.) or HCMV (see 5.2.), which
show enhanced infectivity in the absence of these individual ND10
constituents.
The currently available data implicate ND10 as part of both the
intrinsic as well as the IFN-mediated innate cellular response to viral
infections. It was only recently that intrinsic immune mechanisms
gained substantial interest as they form an antiviral front-line defense
mediated by constitutively expressed proteins, designated as restric-
tion factors, that are already present and active before a virus enters
the cell [200]. The term “intrinsic” was originally used to deﬁne
immunity that functions independent of cytokines and white blood
cells. Thus, it refers to immune defenses that do not respond to viral
infection like the innate immune system (e.g. NK cells and IFN) but
which are ready to act even before the infecting agent is encountered
[200]. Unlike other factors with IFN-dependent antiviral properties
such as Mx proteins or 2′,5′-oligoadenylate synthetase, ND10
components are constitutively expressed which allows for immediate
antiviral activity of these molecules. An effect, which is additionally
potentiated through their IFN-mediated upregulation and by which
ND10 components also contribute to the establishment of an antiviral
state against certain viruses upon IFN induction.
Another characteristical aspect of cellular antiviral defense
mechanisms is the fact that they are subject to viral countermeasures.
Indeed, almost all viruses for which replication has been linked to
ND10, have evolved regulatory proteins that are capable of inactivat-
ing single ND10 components or disturbing the integrity of the whole
subnuclear structure. Inmany cases, these virus-induced alterations to
ND10 composition have already been demonstrated to be important
for the outcome of infection and correlate with the efﬁciency of viral
propagation. Interestingly, however, each virus seems to have
developed its own speciﬁc strategy to cope with the antiviral aspects
of ND10.
Although there is considerable evidence in favor of the view that
ND10 are involved in a cellular response aimed at restricting viral
infection by actively targeting incoming viral components, this
assumption obviously does not generally apply to all viruses as
indicated in case of papillomavirus infection (see 5.5.). In addition, it
cannot be excluded, that, upon initial disruption of ND10 and
inactivation of their antiviral features, these subnuclear loci represent
favorable sites for viral replication and the establishment of replica-
tion centers or progeny virion assembly sites. Nevertheless, the future
challenge will be to get a detailed understanding of the underlying
molecular mechanisms of ND10 as well as of the viral factors
antagonizing its antiviral function since shifting the balance towards
ND10-mediated viral repression could constitute a novel principle
how to ﬁght viral infections.
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